Intracellular Bacteria and Protozoa - Intracellular Delivery: Fundamentals and Applications - page 806

Owais M, Varshney GC, Choudhury A, Chandra S, Gupta CM (1995) Chloroquine encapsulated
in malaria-infected erythrocyte-specific antibody-bearing liposomes effectively controls chlo-
roquine-resistant Plasmodium berghei infections in mice. Antimicrob Agents Chemother 39:
180-184
Owens MD, Warren DA (2010) Salmonella Infection. http://emedicine.medscape.com/
article/785774-overview . Updated: May 20, 2010
Pandey R, Khuller GK (2004) Subcutaneous nanoparticle-based antitubercular chemotherapy in
an experimental model. J Antimicrob Chemother 54: 266-268
Pandey R, Sharma s, Khuller GK (2005) Oral solid lipid nanoparticle based antitubercular chemo-
therapy. Tuberculosis 85: 415-420
Pandey R, Khuller GK (2006) Oral nanoparticle-based antituberculosis drug delivery to the brain
in an experimental model. J Antimicrob Chemother 57: 1146-1152
Pandey R, Zahoor A, Sharma S, Khuller GK (2003 a) Nanoparticle encapsulated antitubercular
drugs as a potential oral drug delivery system against murine tuberculosis. Tuberculosis 83:
373-378
Pandey R, Sharma A, Zahoor A, Sharma S, Khuller GK, Prasad B (2003 b) Poly (DL-lactide-co-
glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental
tuberculosis. J Antimicrob Chemother 52: 981-986
Patton JS, Byron PR (2007) Inhaling medicines: delivering drugs to the body through lungs. Nat
Rev Drug Discov 6: 67-74
Peek LJ, Middaugh CR, Berkland C (2008) Nanotechnology in vaccine delivery. Adv Drug Del
Rev 60: 915-928
Peeters PAM, Brunink BG, Eling WMC, Crommelin DJA (1989 a) Therapeutic effect of chloro-
quine (CQ)-containing immunoliposomes in rats infected with Plasmodium berghei parasit-
ized mouse red blood cells: Comparison with combinations of antibodies and CQ or liposomal
CQ. Biochem Biophys Acta Biomembranes 981: 269-276
Peeters PAM, De Leest K, Eling WMC, Crommelin DJA (1989 b) Chloroquine blood levels after
administration of the liposome-encapsulated drug in relation to therapy of murine malaria.
Pharm Res 6: 787-793
Perrin AJ, Jiang X, Birmingham CL, So NSY, Brumell JH (2004) Recognition of bacteria in the
cytosol of mammalian cells by the ubiquitin system. Curr Biol 14: 806-811
Peters K, Leitzke S, Diederichs JE, Borner K, Hahn H, Müller RH, Ehlers S (2000) Preparation
of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy
in murine Mycobacterium avium infection. J Antimicrob Chemother 45: 77-83
Petray PB, Morilla MJ, Corral RS, Romero EL (2004) In vitro activity of etanidazole against the
protozoan parasite Trypanosoma cruzi . Mem Inst Oswaldo Cruz 99: 233-235
Petrelli F, Borgonovo K, Barni S (2010) Targeted delivery for breast cancer therapy: the history of
nanoparticle-albumin-bound paclitaxel. Expert Opin Pharmacother 11(8): 1413-32
Philips JA (2008) Mycobacterial manipulation of vacuolar sorting. Cell Microbiol 10:
2408-2415
Pirson P, Steiger R, Trouet A (1982) The disposition of free and liposomally encapsulated antima-
larial primaquine in mice. Biochem Pharmacol 31: 3501-3507
Pissuwan D, Valenzuela SM, Miller CM, Cortie MB (2007) A golden bullet? Selective targeting
of Toxoplasma gondii tachyzoites using antibody-functionalized gold nanorods. Nano Letters
7: 3808-3812
Pissuwan D, Valenzuela SM, Miller CM, Killingsworth MC, Cortie MB (2009) Destruction and
control of Toxoplasma gondii tachyzoites using gold nanosphere/antibody conjugates. Small
5(9): 1030-1034
Poelma DL, Zimmermann LJI, Scholten HH, Lachmann B, Iwaarden van JF (2002) In vivo and
in vitro uptake of surfactant lipids by alveolar type II cells and macrophages. Am J Physiol
Lung Cell Mol Physiol 283: L648-L654
Poole K (2005) Efflux mediated antimicrobial resistance. J Antimicrob Chemother 56: 20-51
Postma NS, Hermsen CC, Zuidema J, Eling WMC (1998) Plasmodium vinckei : Optimization of
desferrioxamine B delivery in the treatment of murine malaria. Exp Parasitol 89: 323-330